Current era survival of patients with pulmonary arterial hypertension associated with congenital heart disease: A comparison between clinical subgroups

European Heart Journal

Volumn 35, Issue 11, 2014, Pages 716-724

  Manes, Alessandra ^a   Palazzini, Massimiliano ^a   Leci, Enri ^a   Bacchi Reggiani, Maria L ^a   Branzi, Angelo ^a   Galiè, Nazzareno ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Catheterization; Congenital heart defects; Follow up studies; Haemodynamics; Pulmonary arterial hypertension

Indexed keywords

ANTICOAGULANT AGENT; DIGITALIS; DIURETIC AGENT; ENDOTHELIN RECEPTOR ANTAGONIST; PHOSPHODIESTERASE V; PHOSPHODIESTERASE V INHIBITOR; PROSTANOID;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; BRAIN HEMORRHAGE; CARDIAC PATIENT; CAUSE OF DEATH; COHORT ANALYSIS; COMPARATIVE STUDY; DOWN SYNDROME; EISENMENGER COMPLEX; EXERCISE; FEMALE; FOLLOW UP; FUNCTIONAL STATUS; HEART ATRIUM SEPTUM DEFECT; HEART CATHETERIZATION; HEART LUNG TRANSPLANTATION; HEART VENTRICLE SEPTUM DEFECT; HEMOPTYSIS; HUMAN; KABUKI MAKEUP SYNDROME; LUNG HEMODYNAMICS; LUNG VASCULAR RESISTANCE; LUNG VEIN DRAINAGE ANOMALY; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PATENT DUCTUS ARTERIOSUS; PATIENT REFERRAL; PNEUMONIA; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SUDDEN CARDIAC DEATH; SURVIVAL; SYSTEMIC PULMONARY SHUNT;

CATHETERIZATION; CONGENITAL HEART DEFECTS; FOLLOW-UP STUDIES; HAEMODYNAMICS; PULMONARY ARTERIAL HYPERTENSION;

ADOLESCENT; ADULT; AGED; CHILD; EXERCISE TOLERANCE; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; HYPERTENSION, PULMONARY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME-TO-TREATMENT; YOUNG ADULT;

EID: 84898983249     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/eht072     Document Type: Article

References (22)

1. Adatia I, Kothari SS, Feinstein JA. Pulmonary hypertension associated with congenital heart disease: Pulmonary vascular disease: The global perspective. Chest 2010;137(6 Suppl):52S-61S.
2. Beghetti M, Galiè N. Eisenmenger syndrome: A clinical perspective in a new therapeutic era of pulmonary arterial hypertension. J Am Coll Cardiol 2009;53:733-740
3. Galiè N, Manes A, Palazzini M, Negro L, Marinelli A, Gambetti S, Mariucci E, Donti A, Branzi A, Picchio FM. Management of pulmonary arterial hypertension associated with congenital systemic-To-pulmonary shunts and Eisenmenger's syndrome. Drugs 2008;68:1049-1066
4. Simonneau G, Robbins I, Beghetti M, Channick RN, Delcroix M, Denton CP, Elliott CG, Gaine SP, Gladwin MT, Jing ZC, Krowka MJ, Langleben D, Nakanishi N, Souza R. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009;54:S43-S54
5. Eisenmenger V. Die angeboren defects des kammerscheidewand des herzen. Z Klin Med 1897;32:1-28
6. Galiè N, Hoeper M, Humbert M, Torbicki A, Vachiery JL, Barbera JA, Beghetti M, Corris P, Gaine S, Gibbs JS, Gomez-Sanchez MA, Jondeau G, Klepetko W, Opitz C, Peacock A, Rubin L, Zellweger M, Simonneau G; ESC Committee for Practice Guidelines (CPG). Guidelines on diagnosis and treatment of pulmonary hypertension: The Task Force on Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology and of the European Respiratory Society. Eur Heart J 2009;30:2493-2537
7. Dimopoulos K, Inuzuka R, Goletto S, Giannakoulas G, Swan L, Wort SJ, Gatzoulis MA. Improved survival among patients with Eisenmenger syndrome receiving advanced therapy for pulmonary arterial hypertension. Circulation 2010; 121:20-25
8. Daliento L, Somerville J, Presbitero P, Menti L, Brach-Prever S, Rizzoli G, Stone S. Eisenmenger's syndrome: Factors relating to deterioration and death. Eur Heart J 1998;19:1845-1855. (Pubitemid 28556655)
9. Galie N, Torbicki A, Barst R, Dartevelle P, Haworth S, Higenbottam T, Olschewski H, Peacock A, Pietra G, Rubin LJ, Simonneau G, Priori SG, Garcia MA, Blanc JJ, Budaj A, Cowie M, Dean V, Deckers J, Burgos EF, Lekakis J, Lindahl B, Mazzotta G, McGregor K, Morais J, Oto A, Smiseth OA, Barbera JA, Gibbs S, Hoeper M, Humbert M, Naeije R, Pepke-Zaba J; Task Force. Guidelines on diagnosis and treatment of pulmonary arterial hypertension: The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. Eur Heart J 2004;25:2243-2278
10. Badesch BD, Abman SH, Ahearn GS, Barst RJ, McCrory DC, Simonneau G, McLaughlin VV; American College of Chest Physicians. Medical therapy for pulmonary arterial hypertension. ACCP evidence-based guidelines for clinical practice. Chest 2004;126:35S-62S.
11. McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR, Mathier MA, McGoon MD, Park MH, Rosenson RS, Rubin LJ, Tapson VF, Varga J, Harrington RA, Anderson JL, Bates ER, Bridges CR, Eisenberg MJ, Ferrari VA, Grines CL, Hlatky MA, Jacobs AK, Kaul S, Lichtenberg RC, Lindner JR, Moliterno DJ, Mukherjee D, Pohost GM, Rosenson RS, Schofield RS, Shubrooks SJ, Stein JH, Tracy CM, Weitz HH, Wesley DJ. ACCF/ AHA 2009 expert consensus document on pulmonary hypertension: A report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: Developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association. Circulation 2009;119: 2250-2294
12. Nomenclature Committee. Nomenclature and classification of pulmonary hypertension. In: Rish S ed. Primary Pulmonary Hypertension: Executive Summary from the World Symposium-Primary Pulmonary Hypertension. Geneva, Switzerland: World Health Organization; 1998, pp. 25-27
13. Baumgartner H, Bonhoeffer P, De Groot NMS, De Haan F, Deanfield JE, Galie N, Gatzoulis MA, Gohlke-Baerwolf C, Kaemmerer H, Kilner P, Meijboom F, Mulder BJM, Oechslin E, Oliver JM, Serraf A, Szatmari A, Thaulow E, Vouhe PR, Walma E, Vahanian A, Auricchio A, Bax J, Ceconi C, Dean V, Filippatos G, Funck-Brentano C, Hobbs R, Kearney P, McDonagh T, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Vardas P, Widimsky P, Swan L, Andreotti F, Beghetti M, Borggrefe M, Bozio A, Brecker S, Budts W, Hess J, Hirsch R, Jondeau G, Kokkonen J, Kozelj M, Kucukoglu S, Laan M, Lionis C, Metreveli I, Moons P, Pieper PG, Pilossoff V, Popelova J, Price S, Roos-Hesselink J, Uva MS, Tornos P, Trindade PT, Ukkonen H, Walker H, Webb GD, Westby J. ESC Guidelines for the management of grown-up congenital heart disease. Eur Heart J 2010;31:2915-2957
14. Haworth SG, Hislop AA. Treatment and survival in children with pulmonary arterial hypertension: The UK Pulmonary Hypertension Service for Children 2001- 2006. Heart 2009;95:312-317
15. Barst RJ, McGoon MD, Elliott CG, Foreman AJ, Miller DP, Ivy DD. Survival in childhood pulmonary arterial hypertension: Insights from the registry to evaluate early and long-Term PAH disease management. Circulation 2012;125:113-122
16. Diller GP, Dimopoulos K, Broberg CS, Kaya MG, Naghotra US, Uebing A, Harries C, Goktekin O, Gibbs JS, Gatzoulis MA. Presentation, survival prospects, and predictors of death in Eisenmenger syndrome: A combined retrospective and case-control study. Eur Heart J 2006;27:1737-1742. (Pubitemid 44025362)
17. Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V, Yaíci A, Weitzenblum E, Cordier JF, Chabot F, Dromer C, Pison C, Reynaud-Gaubert M, Haloun A, Laurent M, Hachulla E, Cottin V, Degano B, Jaís X, Montani D, Souza R, Simonneau G. Survival in patients with idiopathic, familial, and anorexigen-Associated pulmonary arterial hypertension in the modern management era. Circulation 2010;122:156-163
18. Hachulla E, Carpentier P, Gressin V, Diot E, Allanore Y, Sibilia J, Launay D, Mouthon L, Jego P, Cabane J, de Groote P, Chabrol A, Lazareth I, Guillevin L, Clerson P, Humbert M; ItinérAIR-Sclérodermie Study Investigators. Risk factors for death and the 3-year survival of patients with systemic sclerosis: The French ItinérAIR-Sclérodermie study. Rheumatology 2009;48:304-308
19. Diller GP, Dimopoulos K, Okonko D, Li W, Babu-Narayan SV, Broberg CS, Johansson B, Bouzas B, Mullen MJ, Poole-Wilson PA, Francis DP, Gatzoulis MA. Exercise intolerance in adult congenital heart disease: Comparative severity, correlates, and prognostic implication. Circulation 2005;112:828-835. (Pubitemid 41170068)
20. Hopkins WE. The remarkable right ventricle of patients with Eisenmenger syndrome. Coron Artery Dis 2005;16:19-25. (Pubitemid 40279593)
21. Engelfriet PM, Duffels MGJ, Moller T, Boersma E, Tijssen JG, Thaulow E, Gatzoulis MA, Mulder BJ. Pulmonary arterial hypertension in adults born with a heart septal defect: The Euro Heart Survey on adult congenital heart disease. Heart 2007;93:682-687. (Pubitemid 46808265)
22. Suissa S. Immortal time bias in pharmaco-epidemiology. Am J Epidemiol 2008;167: 492-499